Site Selection

Facility Planning

Workforce Development

Business+Place

AD Editorial Board

Aaron Ahlburn

Managing Director and Senior Director, Research, JLL
Amy Gerber

Executive Managing Director, Business Incentives Practice, Cushman & Wakefield
Bill Luttrell

Senior Locations Strategist, Werner Global Logistics, Werner Enterprises
Bradley Migdal

Senior Managing Director, Business Incentives Practice, Cushman & Wakefield, Inc.
Brian Corde

Managing Partner, Atlas Insight
Dan Levine

Practice Leader, Location Strategies and Economic Development, Oxford Economics, Inc.
Dan White

Senior Economist, Moody's Analytics
Dean J. Uminski, CEcD

Partner, Crowe Horwath
Dennis Cuneo

Partner , Fisher & Phillips
Eric Stavriotis

Senior Vice President, Advisory & Transaction Services, CBRE, Inc.
Gregory Burkart

Managing Director and City Leader, Site Selection & Incentives Advisory , Duff & Phelps, LLC
H. Robert Boehringer, III

Managing Director, Global Location & Expansion Services, KPMG
Josh Bays

Principal, Site Selection Group, LLC
Joshua Wright

VP, Economic and Workforce Development, Emsi
Kate Crowley

Principal & Negotiated incentives Practice Leader, Baker Tilly Virchow Krause, LLP
Les Cranmer

Senior Managing Director, Savills Studley
Marc Beauchamp

President & CEO, The CAI Global Group
Margy Sweeney

Founder and CEO, Akrete, Inc.
Minah Hall

Managing Director, True Partners Consulting LLC
Paul Naumoff

Principal, National Director of Tax Credits & Incentives Advisory Services, EY Global/Americas
Scott Kupperman

Founder, Kupperman Location Solutions
Stephen Gray

CEO, Gray Construction

AKESOgen Triples Its Peachtree Corners, Georgia, Office-Research Campus

Area Development News Desk

01/03/2014

A genomics and biorepository services company, AKESOgen will more than triple its square footage in Gwinnett County, Metro Atlanta, Georgia, area, with its move to a 13,727-square-foot facility at 3155 Northwoods Place in the City of Peachtree Corners. The company expects to add up to an additional ten employees in 2014.

“Since our inception just over three years ago, we have been impressed with the resources, support, and growth opportunities available to biotech companies in Gwinnett County, metro Atlanta and Georgia,” stated Dr. Mark Bouzyk, Chief Scientific Officer for AKESOgen, Inc. “This larger facility will both strengthen our ability to deliver genomics research and development, as well as complement our existing competence in the biotech field.”

“Innovative life science companies such as AKESOgen are what make our state the healthcare hub of the Southeast,” said Carol Henderson, director of life sciences and technology at the Georgia Department of Economic Development. “AKESOgen will lay the foundation for tomorrow’s life science discovery, and we are confident that Georgia’s pro-business climate can support the company in doing so.”

“Our goal as a region is to broaden and enhance life science and technology in the region and an expansion such as this one demonstrates the success of those efforts,” commented Nick Masino, Chair of Georgia’s Innovation Crescent and Senior Vice President of Gwinnett Chamber Economic Development and Partnership Gwinnett. “As a member of the Innovation Crescent Regional Partnership, Gwinnett Chamber Economic Development actively works to promote, support and encourage the growth of companies in these industries.”

“We welcome AKESOgen, and view its investment in the City of Peachtree Corners and Gwinnett as a testament to our community’s strength in this developing, vibrant and progressive industry,” said City of Peachtree Corners Mayor Mike Mason.

Article Discussion